알레르기성 기도 질환에서 줄기세포 유래 세포외 소포체의 응용
Application of Stem Cell-Derived Extracellular Vesicles in Allergic Airway Diseases
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCI
- 저널
- Journal of Rhinology27(1) · pp.1 · 2020
- 피인용
- KCI 1
- ISSN
- 1229-1498
저자
초록
Mesenchymal stem cells (MSCs) have been reported to be promising candidates for the treatment of allergic airway diseases. However, MSCs themselves have several problems including immune rejection, risk of aneuploidy, difficulty of handling, and tumorigenicity. An increasing number of studies demonstrated that administration of conditioned media or extracellular vesicles (EVs) released by MSCs is as effective as the MSCs themselves in suppression of allergic airway inflammation. EVs can exert their effects by delivering their contents such as proteins, mRNAs, and microRNAs to recipient cells. Furthermore, the administration of MSCs-derived EVs may reduce potential safety risks associated with stem cell therapy, suggesting that MSCs-derived EVs may be a promising alternative to cell therapy for allergic airway diseases. This review examines the current understanding of the immunomodulatory properties of MSCs-derived EVs and its therapeutic implication for allergic airway diseases.
키워드
Mesenchymal stem cellsExtracellular vesiclesAllergic rhinitisAsthmaImmunosuppression.
식별자
- KCI
- ART002592177



로그인
연구물 목록으로